Heart bailout by cell therapy: Introducing an acceptable test for comparing cell accountability

Research output: Contribution to journalArticle

Abstract

Cell therapy for cardiovascular disease is still in its initial phase of development and hence stringent studies are now required for comparison between available approaches using validated experimental models. The best cell for regenerative purposes should have the ability to stimulate vascular repair and cardiomyogenesis in a time-programmable fashion, cooperating with reparative processes afforded by resident cells. However, these requirements are often unreachable with individual cell types currently used in clinical trials as documented by an interesting article from Barclay and colleagues in the current issue of Stem Cell Research and Therapy.

Original languageEnglish
Article number32
JournalStem Cell Research and Therapy
Volume3
Issue number4
DOIs
Publication statusPublished - 2012

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Molecular Medicine
  • Cell Biology
  • Medicine (miscellaneous)
  • Medicine(all)

Fingerprint Dive into the research topics of 'Heart bailout by cell therapy: Introducing an acceptable test for comparing cell accountability'. Together they form a unique fingerprint.

  • Cite this